Company Filing History:
Years Active: 1987-2005
Title: Marvin Simon Hoekstra: Innovator in Pharmaceutical Chemistry
Introduction
Marvin Simon Hoekstra is a notable inventor based in Holland, MI (US), recognized for his contributions to pharmaceutical chemistry. He holds three patents that showcase his innovative approaches to drug synthesis and preparation. His work has significant implications for the treatment of various medical conditions.
Latest Patents
One of Hoekstra's latest patents is focused on the asymmetric synthesis of pregabalin. This invention provides a method for producing (S)-(+)-3-(aminomethyl)-5-methylhexanoic acid, commonly known as pregabalin, or its salts through an asymmetric hydrogenation synthesis. Pregabalin is particularly useful in treating and preventing seizure disorders, pain, and psychotic disorders. Additionally, the invention includes intermediates that are beneficial in the production of pregabalin. Another significant patent by Hoekstra involves the preparation of Bevantolol, which is 1-[3,4-dimethoxyphenethylamine]-3-(m-tolyloxy)-2-propanol. This preparation is enhanced by contacting the reactants at relatively low temperatures, streamlining the synthesis process.
Career Highlights
Hoekstra has made substantial contributions to the field of pharmaceutical development during his career. His innovative methods have not only advanced the synthesis of important compounds but have also improved the efficiency of drug production processes. He is associated with Warner-Lambert Company, where he has applied his expertise in pharmaceutical chemistry.
Collaborations
Throughout his career, Hoekstra has collaborated with several professionals in the field. Notable coworkers include Mark Joseph Burk and Om Prakash Goel, who have contributed to various projects alongside him.
Conclusion
Marvin Simon Hoekstra's work in pharmaceutical chemistry exemplifies innovation and dedication to improving drug synthesis methods. His patents reflect a commitment to advancing medical treatments and enhancing the efficiency of pharmaceutical production.